Identifying the correct cause of hyperprolactinemia is crucial for treatment. Prolactinoma is the most common pathologic cause of hyperprolactinemia. Dopamine agonists are efficacious in about 80% to 90% of patients with prolactinoma, leading to reduction of serum prolactin levels and tumor dimensions. Neurosurgery, mainly by the transsphenoidal route, is indicated in cases of intolerant and re...

Although the diagnosis of prolactinoma is often straightforward and the treatment strategy has been well defined in recent guidelines, several challenging issues persist in their management. The differential diagnosis of a large pituitary tumour with moderately elevated prolactin (PRL) concentrations is sometimes difficult, and prolonged treatment with a dopamine agonist may be inappropriate wh...

objective: prolactinomas are the most common pituitary tumors in pregnant women. we conducted this study on pregnant women with prolactinoma to determine their clinical symptoms and signs and eventual necessity to medical therapy. materials and methods: a descriptive study was performed on 85 pregnant women with prolactinoma.patients were followed up by physical examination, imaging, and perime...

Abstract Pit-1 (POU1F1) is a POU-homeodomain transcription factor, and it one of the most important tissue-specific factors in pituitary development. Cyclin-dependent kinase 5 (CDK5) protein that can phosphorylate many key factors, but mechanism under which CDK5 phosphorylates unclear. To investigate whether regulate cell proliferation promote hormone secretion through phosphorylation Ser126-Pi...

Autoantibodies to cell surface antigens of human somatotropinoma (ASAS), human prolactinoma (ASAP) and rat adenohypophysis (ASARA) were assayed in the serum of patients with pituitary diseases associated with GH deficiency (GHD), such as pituitary dwarfism and primary empty sella syndrome (ESS), and in the serum of patients with hyperprolactinaemia of different etiologies: idiopathic hyperprola...

background and importance: the coexistence of pituitary adenoma and another type of brain tumor is a very rare clinical scenario. even though such a presentation can be an incidental event but the possible pathogenesis of coexistence of different lesions in the sella and suprasellar region has not yet been elucidated. case presentation: two cases of concomitant sellar and suprasellar region tum...

To cite: Sahoo JP, Kamalanathan S, Parida PK, et al. BMJ Case Rep Published online: [please include Day Month Year] doi:10.1136/bcr-2014208811 DESCRIPTION A 35-year-old woman presented to the ear, nose and throat outpatient department with headache and a blocked left-sided nasal canal with epistaxis for 2 years. Medical history revealed secondary amenorrhoea for the past 19 years with regressio...